Close Menu

Over at In the Pipeline, Derek Lowe comments on the fact that slowly but surely, Merck has been getting many of the large Vioxx judgments against it overturned on appeal. Out of 20 that went to court, Merck has won 17. Part of the problem, says Lowe, is that the bad effects (heart attacks) happened to only a few people, compared to the total number who were taking the drug, many of whom didn't need it.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A South African university has told the Wellcome Sanger Institute to return DNA samples it has from indigenous African communities, The Times reports.

The University of California, Berkeley's Rasmus Nielsen and Xinzhu Wei have retracted their CCR5 gene paper due to a technical artifact.

 

University of Virginia researchers are exploring a genetic risk test to gauge type 1 diabetes risk, NPR reports.

In PNAS this week: researchers compare two high-grade neuroendocrine lung cancers, height among ancient Europeans, and more.